These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21950810)

  • 1. Barrett's esophagus: proton pump inhibitors and chemoprevention II.
    Richter JE; Penagini R; Tenca A; Pohl D; Dvorak K; Goldman A; Savarino E; Zentilin P; Savarino V; Watson JT; Wong RK; Pace F; Casini V; Peura DA; Herzig SJ; Kamiya T; Pelosini I; Scarpignato C; Armstrong D; DeVault KR; Bechi P; Taddei A; Freschi G; Ringressi MN; Degli'Innocenti DR; Castiglione F; Masini E; Hunt RH
    Ann N Y Acad Sci; 2011 Sep; 1232():114-39. PubMed ID: 21950810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus.
    Sharaiha RZ; Freedberg DE; Abrams JA; Wang YC
    Dig Dis Sci; 2014 Jun; 59(6):1222-30. PubMed ID: 24795040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's esophagus: proton pump inhibitors and chemoprevention I.
    Triadafilopoulos G; Taddei A; Bechi P; Freschi G; Ringressi MN; Degli'Innocenti DR; Castiglione F; Masini E; Majewski M; Wallner G; Sarosiek J; Dillon JF; McCallum RC; Dvorak K; Goldman A; Woodland P; Sifrim D; Richter JE; Vieth M; Neumann H; Langner C; Ishimura N; Amano Y; Felix VN
    Ann N Y Acad Sci; 2011 Sep; 1232():93-113. PubMed ID: 21950809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
    Dunbar KB; Souza RF; Spechler SJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Acid Suppression in Barrett's Esophagus.
    Elias PS; Castell DO
    Am J Med; 2017 May; 130(5):525-529. PubMed ID: 28159599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status of Chemoprevention in Barrett's Esophagus.
    Moayyedi P; El-Serag HB
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):117-130. PubMed ID: 33213791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of Barrett's oesophagus: a step closer with PPIs and aspirin.
    Husain NS; El-Serag HB
    Nat Rev Clin Oncol; 2018 Dec; 15(12):728-730. PubMed ID: 30237519
    [No Abstract]   [Full Text] [Related]  

  • 8. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)?
    Spechler SJ
    Dig Dis; 2014; 32(1-2):156-63. PubMed ID: 24603402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transepithelial leak in Barrett's esophagus patients: the role of proton pump inhibitors.
    Farrell C; Morgan M; Tully O; Wolov K; Kearney K; Ngo B; Mercogliano G; Thornton JJ; Valenzano MC; Mullin JM
    World J Gastroenterol; 2012 Jun; 18(22):2793-7. PubMed ID: 22719187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting Proton Pump Inhibitors as Chemoprophylaxis Against the Progression of Barrett's Esophagus.
    Shah SL; Dunbar K
    Curr Gastroenterol Rep; 2023 Dec; 25(12):374-379. PubMed ID: 37940812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
    Menges M; Müller M; Zeitz M
    Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
    Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?
    Akın H; Aydın Y
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S31-S32. PubMed ID: 29199164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus.
    Gaber CE; Abdelaziz AI; Sarker J; Lund JL; Dellon ES; Cotton CC; Eluri S; Shaheen NJ
    Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5760. PubMed ID: 38362648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
    Tan MC; El-Serag HB; Yu X; Thrift AP
    Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.
    Basu KK; Bale R; West KP; de Caestecker JS
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1187-92. PubMed ID: 12439112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparison of medical versus surgical treatment in Barrett's esophagus acid control].
    Fernández Fernández N; Domínguez Carbajo AB; João Matias D; Rodríguez-Martín L; Aparicio Cabezudo M; Monteserín Ron L; Jiménez Palacios M; Vivas S
    Gastroenterol Hepatol; 2016 May; 39(5):311-7. PubMed ID: 26545949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.